Jadwal Imunisasi Anak Usia 0 – 18 Tahun Rekomendasi Ikatan Dokter Anak Indonesia Tahun 2023
Sari
Satuan Tugas Imunisasi Ikatan Dokter Anak Indonesia (IDAI) secara berkala mengevaluasi jadwal imunisasi untuk menyesuaikan dengan vaksin baru, program imunisasi Kemenkes, WHO position paper dan sumber-sumber lain. Di dalam jadwal imunisasi rekomendasi IDAI tahun 2023 ini ada beberapa tambahan antara lain vaksin dengue baru, dan keterangan tambahan beberapa vaksin lain. Untuk memudahkan dalam melaksanakannya dilampirkan juga tabel jadwal imunisasi tahun 2023. Untuk memahami dasar pertimbangan jadwal imunisasi dan perubahannya perlu mempelajari uraian di dalam artikel ini dan keterangan di bawah tabel tersebut untuk diterapkan ke dalam layanan imunisasi.
Kata Kunci
Teks Lengkap:
PDFReferensi
World Health Organization. Hepatitis B vaccine: WHO position paper – July 2017. Wkly Epidemiol Rec 2017;27:389-90.
American Academy of Pediatrics. Hepatitis B. Dalam: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, penyunting. Red Book: 2021 Report of the committee on infectious diseases. Itasca, IL: Am Acad Pediatr 2021:381-98.
Omenaca F, Garcia-Sicilia J, Garcia-Corbeira P, Boceta R, Romero A, Lopez G, Dal-Re R. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005;116:1292-8.
Menteri Kesehatan RI. Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/15/2023 Tentang Percontohan Pemberian Antivirus Pada Ibu Hamil Untuk Pencegahan Transmisi Virus Hepatitis B Dari Ibu Ke Anak. Jakarta: Kemenkes RI; 2023.
World Health Organization. Polio vaccine: WHO position paper-June 2022. Wkly Epidemiol Rec 2022;97:277-300.
Mphahlele MJ, Mda S. Immunising the HIV-infected child: a view from sub-Saharan Africa. Vaccine 2012;30:C61–C65.
Global Polio Eradication Initiative. This week. Polio this week as 29 March 2023. Diunduh 29 Maret 2023. Didapat dari: https://polioeradication.org/polio-today/polio-now/this-week.
Yeh M Te, Bujaki E, Dolan PT, Smith M, Wahid R, Konz J, dkk. Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence. Cell Host Microbe. 2020;27:736-751.e8. Diunduh 29 Maret 2023. Didapat dari: https://doi.org/10.1016/j.chom.2020.04.003.
World Health Organization. BCG vaccines: WHO position paper - February 2018. Wkly Epidemiol Rec 2018;8:73-96.
Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA. Systematic review and meta-analysis of the current evidence on the duration of protection by Bacillus Calmette–Guérin vaccination against tuberculosis. Health Technol Assess 2013;17:1-372.
Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE. Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials. Clin Infect Dis 2014;58:470-80.
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tahun 2017 Tentang Penyelenggaraan Imunisasi. Jakarta: Kemenkes RI; 2017.
Kementerian Kesehatan RI. Petunjuk tehnis bulan imunisasi anak nasional (BIAN), Direktorat Jenderal Pencegahan dan pengendalian penyakit.Jakarta: Kemenkes RI; 2022.
World Health Organization. Diphtheria vaccine: WHO position paper – August 2017. Wkly Epidemiol Rec 2017;31:417-36.
World Health Organization. Pertussis vaccine: WHO position paper – August 2015. Wkly Epidemiol Rec 2015;35:433-60.
World Health Organization. Tetanus vaccine: WHO position paper – February 2017. Wkly Epidemiol Rec 2017;6:53-76.
World Health Organization. Haemophilus influenzae type b (Hib): WHO position Paper - July 2013. Wkly Epidemiol Rec 2013;88:413-26.
World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper - February 2019. Wkly Epidemiol Rec 2019;8:85-104.
Kementerian Kesehatan RI. Keputusan Menteri Kesehatan Republik Indonesia No HK.01.07/MENKES/779/2022 tentang Pemberian Imunisasi Pneumokokus Konyugasi (PCV). Jakarta: Kemenkes RI; 2022.
Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6–18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2013;62:521-4.
Berman-Rosa M, O’Donnell S, Barker M, Quach C. Efficacy and effectiveness of the PCV-10 and PCV-13 vaccines against invasive pneumococcal disease. Pediatrics 2020 Apr;145:e20190377.
Kementerian Kesehatan RI. Petunjuk Teknis Pemberian Imunisasi Rotavirus (RV). Jakarta: Kemenkes RI; 2022.
Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, dkk. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2021;11:CD008521.
Lu H-L, Ding Y, Goyal H, Xu H-G. Association between rotavirus vaccination and risk of intussusception among neonates and infants: A systematic review and meta-analysis. JAMA Netw open 2019;2:e1912458.
Koch J, Harder T, von Kries R, Wichmann O. Risk of intussusception after rotavirus vaccination. Dtsch Arztebl Int 2017;114:255-62.
McGeoch LJ, Finn A, Marlow RD. Impact of rotavirus vaccination on intussusception hospital admissions in England. Vaccine 2020;38:5618–26.
Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, dkk., Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season. MMWR Recomm Rep 2021;70:1-28.
Blumberg EA. MMWR update on seasonal influenza vaccines. Am J Transplant 2013;13:3282–3.
Gemmill I, Young K. Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults. Can Commun Dis Rep 2018;44:129-33.
World Health Organization. Varicella and herpes zoster vaccine: WHO position paper –June 2014. Wkly Epidemiol Rec 2014;89:265–88.
World Health Organization. Japanese encephalitis vaccines: WHO position paper-February 2015. Wkly Epidemiol Rec 2015;9:69-79.
Kementerian Kesehatan RI. Pelaksanaan kampanye dan introduksi imunisasi Japanese Encephalitis di Provinsi Bali. Kemenkes RI; 2017;1-5.
Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global Varicella Vaccine Effectiveness: A Meta-analysis. Pediatrics 2016;137:e20153741.
Zhu S, Zeng F, Xia L, He H, Zhang J. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: Results from a meta-analysis. Am J Infect Control 2018;46:e1-e7.
World Health Organization. Hepatitis A vaccine: WHO Position Paper-October 2022. Wkly Epidemiol Rec 2022;97:493-512.
World Health Organization. Typhoid vaccine: WHO position paper - March 2018. Wkly Epidemiol Rec 2018;13:153–72.
World Health Organization. Human papillomavirus vaccines : WHO position paper- December 2022. Wkly Epidemiol Rec 2022;97:645-72.
Kementerian Kesehatan RI. Pelaksanaan demonstrasi pemberian imunisasi HPV di Surabaya, Manado dan Makasar. Keputusan Menteri Kesehatan no HK 01.07/Menkes/194/2017; 11 April 2017. Jakarta: Kemenkes RI; 2017.
Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev 2018; 5: CD009069.
Schwarz TF, Huang LM, Valencia A, Panzer F, Chiu CH, Decreux A, dkk. A ten-year study of immunogenicity and safety of the AS04- HPV-16/18 vaccine in adolescent girls aged 10-14 years. Hum Vaccin Immunother. 2019;15:1970-79.
Mariz FC, Gray P, Bender N, Eriksson T, Kann H, Apter D, dkk. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomized, double-blind, multicentre, phase 3 trials. Lancet Infect Diseases. 2021;21:1458-68.
Kjaer SK, Nygård M, Sundström K, Munk C, Berger S, Dzabic M, dkk. Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up, Hum Vaccin Immunother 2021;17: 943-49
Wilder-Smith A. Dengue vaccine development by the year 2020: challenges and prospects. Curr Opin Virol 2020;43:71-8.
Prompetchara E, Ketloy C, Thomas SJ, Ruxrungtham K. Dengue vaccine: Global development update. Asian Pac J Allergy Immunol 2020 Sep;38:178-85.
Capeding MR, Tran NH, Hadinegoro SRS, Ismail HIHM, Chotpitayasunondh T, Chua MN, dkk. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet [Internet] 2014;384:1358-65.
Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, dkk. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 2015;373:1195-206.
Rivera L, Biswal S, Sáez-Llorens X, Reynales H, López-Medina E, Borja-Tabora C, dkk. Three-year efficacy and safety of Takeda’s dengue vaccine candidate (TAK-003). Clin Infect Dis an Off Publ Infect Dis Soc Am 2022;75:107-17.
Tricou V, Folschweiller N, Lloyd E, Rauscher M, Biswal S. Efficacy and Safety of Takeda’s Tetravalent Dengue Vaccine Candidate (TAK-003) After 4.5 Years of Follow-Up. 8th North Eur Conf Travel Med. 2022. Diunduh 20 Mei 2023. Didapat dari: https://icmmworldcongress2021.org/slides/theme1/Vianney_Tricou.pdf.
World Health Organization. Dengue vaccine: WHO position paper -September 2018. Wkly Epidemiol Rec 2018;93:457-76.
Wallace AS, Mantel C, Mayers G, Mansoor O, Gindler JS, Hyde TB. Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: Lessons for vaccine introduction. Vaccine 2014;32:5301–10.
World Health Organization (WHO). Reducing pain at the time of vaccination: WHO position paper – September 2015. Wkly Epidemiol Rec 2015;90:505-10.
Dolan SB, Patel M, Hampton LM, Burnett E, Ehlman DC, Garon J, dkk. Administering multiple injectable vaccines during a single visit - summary of findings from the accelerated introduction of inactivated polio vaccine globally. J Infect Dis 2017;216:S152–60.
Payton T, Girgenti D, Frenck RW, Patterson S, Love J, Razmpour A, dkk. Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United States. Pediatr Infect Dis J 2013;32:871-80.
DOI: http://dx.doi.org/10.14238/sp25.1.2023.64-74
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc-sa4.footer##
Email: editorial [at] saripediatri.org
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.